1 / 19

Peng-Hui Wang, M.D., Ph.D. Department of Obstetrics and Gynecology

Peng-Hui Wang, M.D., Ph.D. Department of Obstetrics and Gynecology Taipei Veterans General Hospital National Yang-Ming University 王 鵬 惠 台北榮民總醫院婦產部 國立陽明大學醫學院婦產科學系 5 May 2008. 王 鵬 惠. Submucosal fibroids. Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠. Submucosal fibroids.

ndoris
Download Presentation

Peng-Hui Wang, M.D., Ph.D. Department of Obstetrics and Gynecology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Peng-Hui Wang, M.D., Ph.D. Department of Obstetrics and Gynecology Taipei Veterans General Hospital National Yang-Ming University 王 鵬 惠 台北榮民總醫院婦產部 國立陽明大學醫學院婦產科學系 5 May 2008 王 鵬 惠

  2. Submucosal fibroids Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  3. Submucosal fibroids • the strongest association with lower ongoing pregnancy rates • odds ratio, 0.5, 95% CI=0.3-0.8, • primarily through decreased implantation 王 鵬 惠 Klatky PC et al. AJOG 2008;198:357-66.

  4. Intramural fibroids Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  5. 信者恆信 Inramural fibroids • Cumulative pregnancy rates appeared slightly lower in patients with intramural fibroids 36.9% vs 41.1%, which may reflect biases in the literature • Experienced more miscarriages, 20.4% vs 12.9%. Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  6. Fibroids and Obstetric Outcomes + + Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  7. Obstetric outcomes & fibroids + ? + Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  8. Obstetric outcomes & fibroids Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  9. Obstetric outcomes & fibroids • Adverse obstetric outcomes are rare and may reflect age or other differences in fibroid populations. • Increased risk of • malpresentation (OR=2.9; 95% CI=2.6-3.2), • cesarean (OR=3.7; 95% CI=3.5-3.9), • preterm delivery (OR= 1.5; 95% CI=1.3-1.7) • The incidence of labor dystocia was low (7.5%). Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  10. Inramural or subserosal fibroids • There was no conclusive evidence that intramural or subserosal fibroids adversely affect fecundity. Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  11. Myomectomy or UAE (UVO) • More prospective, controlled trials are needed to assess the effects of myomectomy or UAE (UVO). • Good maternal and neonatal outcomes are expected in pregnancies with uterine fibroids. 睜眼說瞎話 Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  12. Myomectomy or UAE (UVO) Klatky PC et al. AJOG 2008;198:357-66. Klatky PC et al. AJOG 2008;198:357-66. 王 鵬 惠

  13. Our experience and recommendation Peng-Hui Wang, M.D., Ph.D. Department of Obstetrics and Gynecology Taipei Veterans General Hospital National Yang-Ming University 王 鵬 惠 台北榮民總醫院婦產部 國立陽明大學醫學院婦產科學系 5 May 2008 王 鵬 惠

  14. Myomectomy Fertil Steril http://dx.doi.org/10.1016/j.fertnstert.2007.10.006. 王 鵬 惠

  15. LUVO 王 鵬 惠

  16. 王 鵬 惠

  17. Recommendations • Basically, the choice of uterine myoma treatment depends on the patient’s age, the reason for treatment, the issue of fertility preservation, and the patient’s preference. Fertil Steril http://dx.doi.org/10.1016/j.fertnstert.2008.02.134. 王 鵬 惠

  18. Recommendations • No symptoms, no treatment. • The method in the management of myomas has been multidisciplinary in the past years, including an expectant management, medical therapy, surgical intervention, uterine artery embolization, or ablative techniques. • Frequently, these relative less invasive procedures are designed to retain the uterus. • An interesting and relatively well conducted study was requested. Expert Opin Emerg Drugs. 2008 Mar;13(1):119-33. 王 鵬 惠

  19. 問 題 及 討 論 王 鵬 惠

More Related